US Corporate Distress Financial Stress SEC Filings — June 23, 2026

23-06-2026

Fortress Private Lending Fund, through its borrower FPLF NS Holdings Finance LLC, entered into Amendment No. 3 to its Credit Agreement dated June 17, 2026, with lenders including The Bank of Nova Scotia and Sumitomo Mitsui Trust Bank. The amendment modifies certain terms of the existing credit facility, with all lenders consenting and no defaults continuing. No specific financial figures or performance metrics were disclosed in this filing.

• · The amendment was executed on June 17, 2026, and filed on June 23, 2026.
• · The Credit Agreement was originally dated November 7, 2025, and had been amended twice before (Amendment No. 1 on January 19, 2026; Amendment No. 2 on May 13, 2026).
• · All lenders party to the Credit Agreement consented to this amendment.
• · The Rating Condition was satisfied as a condition precedent to the amendment.
• · The Borrower, Subsidiary Guarantor, and Servicer represented that no Default or Event of Default was continuing and that all Coverage Tests, Concentration Limitations, Collateral Quality Tests, and the Portfolio Advance Rate Test were satisfied both before and after the amendment.

23-06-2026

Data I/O Corporation announced the closing of a $9 million investment from two institutional investors, consisting of common stock, convertible debentures, and warrants. The funds are intended for working capital, general corporate purposes, and potential strategic acquisitions. However, the financing is subject to stockholder approval for full conversion and warrant exercise, and the securities are unregistered, posing resale restrictions.

• · Warrants have an exercise price of $3.00 per share and a 5-year term.
• · Convertible debentures are unsecured and mature on the fifth anniversary of issuance.
• · Series B preferred stock is non-voting and convertible into common stock at $2.50 per share.
• · The convertible debentures automatically convert into Series B preferred stock upon stockholder approval at an upcoming shareholders meeting.
• · Data I/O intends to use proceeds for working capital, general corporate purposes, and potential future strategic acquisitions.

23-06-2026

Manulife Private Credit Fund (the Company) is being acquired by John Hancock Comvest Private Income Fund (the Acquiror) through a two-step merger process, with Merger Sub first merging into the Company, followed by the Surviving Company merging into the Acquiror. The transaction, structured as a tax-free reorganization under Section 368(a) of the Code, will see Company shareholders receive Acquiror Class I Common Shares based on a yet-to-be-determined Exchange Ratio after the June 30, 2026 valuation. Both boards have unanimously approved the deal as fair and in the best interests of shareholders, with no dilution expected from the transaction.

• · The merger is structured as a two-step process: first Merger Sub merges into the Company, then the Surviving Company merges into the Acquiror.
• · The transaction is intended to qualify as a reorganization under Section 368(a) of the Internal Revenue Code.
• · Closing will occur on the first day of the month after conditions are satisfied, but no earlier than completion of the June 30, 2026 valuation process.
• · Company Common Shares owned by the Acquiror or its subsidiaries (including Merger Sub) will be cancelled and no consideration will be paid for them.
• · Shareholders will receive cash in lieu of fractional shares of Acquiror Class I Common Shares.
• · The Exchange Ratio will be adjusted for any stock splits, dividends, or reclassifications between the Determination Date and the Effective Time.

23-06-2026

John Hancock Comvest Private Income Fund (Acquiror) has entered into a definitive Agreement and Plan of Merger to acquire Manulife Private Credit Fund (Company) through a two-step merger process, with the Company first merging into a wholly-owned subsidiary and then into the Acquiror. The transaction is structured as a tax-free reorganization under Section 368(a) of the Code, with Company shareholders receiving Acquiror Class I Common Shares based on a formulaic Exchange Ratio tied to net asset values determined after June 30, 2026. The merger is subject to shareholder approvals from both entities and other customary conditions, with the boards of both companies having unanimously approved the transaction as fair and in the best interests of their respective shareholders.

• · The merger is structured as two sequential mergers: first Merger Sub merges into the Company, then the Surviving Company merges into the Acquiror.
• · Company shareholders will receive Acquiror Class I Common Shares at an Exchange Ratio to be finally determined after the June 30, 2026 valuation process.
• · No fractional shares of Acquiror Class I Common Shares will be issued; cash will be paid in lieu of fractional shares.
• · The closing is targeted for the first day of the month after all conditions are satisfied or waived, but no earlier than completion of the June 30, 2026 quarterly valuation.
• · The Company Board and Acquiror Board each unanimously determined the transaction is fair, advisable, and in the best interests of their respective shareholders and that existing shareholders' interests will not be diluted.
• · The parties intend the Mergers to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.

23-06-2026

Nuvectis Pharma announced a strategic portfolio expansion via a license agreement with Haisco Pharmaceutical Group for exclusive ex-China rights to two clinical-stage compounds: NXP100 (a once-daily oral Complement Factor B inhibitor for complement-mediated diseases) and NXP200 (a brain-penetrant paradox-breaker BRAF inhibitor for BRAF-mutated malignancies). The deal includes upfront and near-term payments of up to $40 million, potential milestone payments up to $1.421 billion, and tiered royalties. While NXP100 has shown superior efficacy over eculizumab in Phase 3 PNH trials (59.5% vs 8.3% achieving hemoglobin normalization), the company faces significant financing conditions to meet capital requirements for development, and both compounds are still in clinical stages with no FDA approvals.

• · NXP100 composition of matter patents expire in 2043; NXP200 patents expire in 2042.
• · NXP200 demonstrated a >40% response rate in low- and high-grade adult glioma, including one Complete Response.
• · NXP200 is currently in a Phase 1b study in China; a second-generation salt form shows improved PK and greater clinical activity.
• · Haisco retains rights for NXP100 in India and certain Southeast Asia territories.
• · The agreement is subject to financing conditions that Nuvectis must meet to ensure sufficient capital for development.
• · Fabhalta (iptacopan) is the only FDA-approved Complement Factor B inhibitor, with approvals in PNH, IgAN, and C3G.
• · NXP100 is administered once daily vs Fabhalta's twice-daily dosing.
• · Nuvectis will hold a conference call on June 22, 2026 at 8:30 AM ET.

23-06-2026

FMC Corp entered into a framework agreement to sell its Newark, Delaware property to Ercor Elkton, LLC for approximately $114 million in gross cash proceeds, with proceeds expected to be used to pay down debt. The transaction includes a leaseback of actively operated facilities to minimize disruption to research operations at the Stine Research Center. However, the agreement is subject to due diligence and other conditions, and there is no assurance the transaction will close.

• · The property is part of FMC's Stine Research Center campus in Delaware.
• · FMC will retain ownership of the adjacent Maryland property.
• · The transaction is expected to close in Q4 2026.
• · The leaseback agreement terms are still preliminary and subject to negotiation.
• · FMC does not expect any impact to its research and development capabilities.

23-06-2026

AMC Entertainment Holdings announced a registered direct offering of 95,250,000 shares of common stock at a price of approximately $2.10 per share, expected to raise gross proceeds of $200 million. The net proceeds will be used to redeem $125.5 million of 6.125% Senior Subordinated Notes due 2027, pay related fees, and for general corporate purposes including debt repayment and strengthening cash reserves. The offering is expected to close on June 24, 2026, with Roth Capital Partners as sole placement agent.

• · The offering is being made under a shelf registration statement on Form S-3 (File No. 333-293291) filed on February 9, 2026.
• · AMC operates approximately 850 theatres and 9,600 screens globally.
• · The company intends to use net proceeds to redeem $125.5 million of 6.125% Senior Subordinated Notes due 2027.

23-06-2026

CIMG Inc. entered into securities purchase agreements on June 17, 2026, to issue up to 43.33 billion units at $0.015 per unit for aggregate gross proceeds of up to $650 million, payable in Bitcoin or USD. The initial closing on June 22, 2026, raised approximately $13.5 million through the issuance of 900 million units, with all related warrants exercised, resulting in 1.8 billion shares issued. However, the massive dilution from the potential issuance of up to 43.33 billion shares raises significant concerns for existing shareholders.

• · The warrants have a two-year exercise period from issuance and can be exercised for cash in USD or Bitcoin.
• · The purchase price in Bitcoin is based on a reference price of $65,000 per Bitcoin unless otherwise agreed.
• · Stockholder approval was obtained on December 24, 2025, for Nasdaq Listing Rule 5635(d) compliance.
• · The offering was made under a registration statement on Form S-1 (SEC File No. 333-294624).

23-06-2026

Fastenal Company entered into a Second Amended and Restated Credit Agreement dated June 18, 2026, establishing an $835,000,000 revolving credit facility with Wells Fargo Bank as Administrative Agent, Swingline Lender, and Issuing Lender, and Wells Fargo Securities and PNC Capital Markets as Joint Lead Arrangers. The facility replaces the prior Amended and Restated Credit Agreement dated September 28, 2022, and includes pricing grids tied to the Consolidated Total Leverage Ratio, with margins ranging from 1.000% to 1.375% over Term SOFR and commitment fees from 0.100% to 0.175%.

• · The credit agreement includes a provision for incremental increases in commitments (Section 4.13).
• · The facility matures on the Revolving Maturity Date, with an extension option under Section 4.16.
• · Financial covenants include a Consolidated Total Leverage Ratio test (Section 8.4).
• · The agreement contains standard representations, affirmative and negative covenants, and events of default.
• · The pricing grid adjusts quarterly based on the Borrower's Consolidated Total Leverage Ratio, with a fallback to Pricing Level IV if compliance certificates are not timely delivered.

23-06-2026

TON Strategy Company (TONX) received a Letter of Reprimand from Nasdaq on June 18, 2026, for inadvertently issuing equity awards in excess of the shareholder-approved 2019 Stock and Incentive Compensation Plan, violating Nasdaq Listing Rule 5635(c). Nasdaq determined the violations were not deliberate and opted for a reprimand rather than delisting, allowing TONX shares to continue trading. The company self-reported the issue, obtained shareholder ratification for prior grants, and rescinded recent grants to officers and directors, closing the matter with no further action required.

• · The Reprimand Letter was issued under Nasdaq Listing Rule 5810(c)(4).
• · The company self-reported the violation on March 27, 2026, and received an Initial Letter from Nasdaq on March 30, 2026.
• · The Excess Awards were issued under the 2019 Plan, which had been amended.
• · The company rescinded recent grants to officers and directors as part of remediation.
• · No financial penalties or monetary amounts were mentioned in the filing.

23-06-2026

Zoomcar Holdings, Inc. completed a second closing of its private placement on June 18, 2026, issuing 662 Series A Units at $1,000 per Unit for aggregate gross proceeds of approximately $537,000. The offering, conducted with accredited investors and placement agent ThinkEquity LLC, allows for up to $5,000,000 in Units plus an additional $5,000,000 overallotment option, with a minimum subscription threshold of $1,000,000 already satisfied. The Preferred Shares are convertible into common stock at $0.05 per share and the warrants have an exercise price of $0.0625 per share, expiring in five years.

• · The offering is scheduled to terminate on June 30, 2026, unless extended by the company.
• · Subscription amounts were held in escrow with CSC Delaware Trust Company pending the second closing.
• · The Preferred Shares have an initial conversion price of $0.05 per share, subject to adjustment including alternate conversion and price-reset provisions.
• · The Warrants have an exercise price of $0.0625 per share and expire five years from issuance.
• · The company must file a resale registration statement within 15 calendar days after the second closing and use best efforts to make it effective.
• · The Registration Rights Agreement includes partial liquidated damages if registration obligations are not met.
• · The securities were offered under Section 4(a)(2) and Rule 506(c) of Regulation D, relying on accredited investor status.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

23-06-2026

IBM extended its $2.5B three-year revolving credit facility to June 20, 2029, with commitments from 21 lenders led by JPMorgan Chase. The extension was confirmed by the administrative agent on June 22, 2026, following an extension request from IBM. No negative or flat metrics are present in this filing.

• · The original credit agreement was dated June 22, 2021, and had been amended twice before (June 30, 2022 and June 20, 2025).
• · The extension request was delivered by IBM on June 2, 2026.
• · The new termination date for the extended commitments is June 20, 2029.
• · The largest individual commitments are $175M each from JPMorgan Chase, BNP Paribas, Citibank, and Royal Bank of Canada.
• · The smallest commitments are $84.375M each from eight lenders including Banco Bilbao Vizcaya Argentaria, Canadian Imperial Bank of Commerce, Goldman Sachs, Societe Generale, The Bank of Nova Scotia, The Toronto-Dominion Bank, Truist Bank, and U.S. Bank.

23-06-2026

DevvStream Corp. (DEVS) received a delisting determination from Nasdaq on June 22, 2026, due to noncompliance with the $1.00 minimum bid price rule and failure to demonstrate compliance with the net income rule. The company's common shares will be suspended from trading on Nasdaq at the open of business on June 24, 2026, unless a stay is granted. DevvStream intends to appeal the decision to the Nasdaq Listing and Hearing Review Council, but the appeal will not stay the suspension, and the company expects its shares to trade on the Pink Limited Market under the same symbol, with a potential application to the OTCQB Market.

• · The delisting determination is based on noncompliance with Nasdaq Listing Rule 5550(a)(2) (minimum bid price) and Listing Rule 5550(b) (net income rule).
• · The company's common shares will be suspended from trading on Nasdaq at the open of business on June 24, 2026.
• · The company intends to request an appeal to the Nasdaq Listing and Hearing Review Council, but the appeal will not stay the suspension.
• · If suspended, the shares are expected to be immediately eligible for quotation on the Pink Limited Market under the symbol DEVS.
• · The company anticipates filing an application to have the shares quoted on the OTCQB Market, but there is no assurance a market will develop or be maintained.
• · There is no assurance the company will succeed in its appeal or be able to satisfy any conditions imposed by the Listing Council.

23-06-2026

Beazer Homes USA, Inc. closed its offering of $400 million 8.000% Senior Unsecured Notes due 2032. The net proceeds will refinance $357.3 million of the company's 5.875% Senior Notes due 2027, with the remainder used for general corporate purposes.

• · The offering was private, exempt from SEC registration under Rule 144A and Regulation S.
• · Any remaining proceeds after redeeming the 2027 Notes will be used for general corporate purposes.
• · Beazer Homes is headquartered in Atlanta, Georgia, and builds homes in 13 states: Arizona, California, Delaware, Florida, Georgia, Indiana, Maryland, Nevada, North Carolina, South Carolina, Tennessee, Texas, and Virginia.
• · The company highlights energy-efficient construction and a Mortgage Choice program offering multiple lender options.

23-06-2026

PG&E Corp and its subsidiary Pacific Gas and Electric Company entered into amendments to their revolving credit agreements on June 22, 2026. The utility subsidiary's credit facility was increased from $5.4B to $6.25B and its maturity extended to June 20, 2031, while the parent company's facility maturity was extended to June 22, 2029 with modified pricing and collateral release terms tied to achieving investment-grade credit ratings.

• · The Utility Amendment extended the maturity date to June 20, 2031.
• · The Corporation Amendment extended the maturity date to June 22, 2029.
• · Collateral release for the Corporation facility requires senior unsecured investment grade ratings from at least two agencies, no Event of Default, and secured indebtedness ≤ $250M.
• · The lien on collateral will be reinstated if PG&E Corp fails to maintain investment grade ratings from at least two agencies or has more than $250M of secured indebtedness outstanding.

23-06-2026

UroGen Pharma Ltd. filed an 8-K on June 23, 2026, to adopt amended Articles of Association, updating governance provisions including share issuance authority, class rights modification, and capital structure flexibility. The changes codify existing practices under Israeli law and NASDAQ rules, with no immediate financial impact. No material operational or financial metrics were disclosed, and investor rights remain largely unchanged.

• · Ordinary shares have nominal value of NIS 0.01 each.
• · Board is authorized to issue shares, options, warrants, or other securities without shareholder approval, subject to applicable law.
• · Company may donate reasonable amounts even if not for business purposes.
• · Shares are uncertificated unless the Board decides otherwise.
• · Transfer of shares requires proper instrument; DTC shares transfer per DTC policies.

23-06-2026

SharpLink Gaming, Inc. (SBET) announced a $75 million registered direct offering priced at $7.49 per share and warrant, representing a 41% premium to its last closing price of $5.29. The company, which holds 875,776 ETH, plans to use proceeds for working capital, additional ETH accumulation, and share repurchases. While the premium pricing signals strong investor confidence, the offering dilutes existing shareholders by 10,013,351 shares, and the company's reliance on volatile ETH holdings introduces significant financial risk.

• · The offering is being made under an effective shelf registration statement on Form S-3ASR (File No. 333-287708) declared effective on May 30, 2025.
• · The warrants have an exercise price of $8.15 per share, are exercisable immediately, and expire four years from issuance.
• · The company intends to use net proceeds for working capital, additional ETH accumulation, and share repurchases under its stock repurchase program.
• · SharpLink describes itself as 'one of the world’s largest corporate holders of Ether' and an 'institutional-grade Ethereum treasury platform.'
• · The company also operates an online affiliate marketing business in addition to its Ethereum treasury platform.

23-06-2026

Jack in the Box Inc. completed a $500 million securitized financing facility through the sale of Series 2026-1 7.624% Fixed Rate Senior Secured Notes, Class A-2, with net proceeds used to repay existing Series 2019-1 4.476% notes and a portion of Series 2022-1 3.445% notes. The company also entered into a $150 million variable funding note facility to replace its existing revolving credit line. While the refinancing extends maturities to 2029 and supports the 'JACK on Track' plan, the new fixed-rate notes carry a significantly higher interest rate (7.624%) compared to the replaced notes (4.476% and 3.445%), increasing interest expense.

• · The new fixed-rate notes carry a 7.624% interest rate, significantly higher than the 4.476% and 3.445% rates on the replaced notes.
• · The next anticipated repayment date is in 2029, clearing near-term maturities.
• · The $150 million variable funding note facility replaces the existing $150 million Series 2022-1 Variable Funding Senior Secured Notes, Class A-1.
• · Jack in the Box operates approximately 2,128 restaurants across 24 states, Guam and Mexico.

23-06-2026

Fiserv completed a €1.0B dual-tranche Euro note offering on June 23, 2026, issuing €500M of 3.750% Senior Notes due 2030 and €500M of 4.250% Senior Notes due 2034. The notes are senior unsecured obligations and include customary change-of-control repurchase provisions at 101% of principal plus accrued interest. The offering was registered under an existing shelf registration statement.

• · The notes were issued under an Indenture dated November 20, 2007, as supplemented by a Thirty-Ninth Supplemental Indenture (2030 Notes) and a Fortieth Supplemental Indenture (2034 Notes).
• · Interest on the 2030 Notes is payable annually on October 15, beginning October 15, 2026; interest on the 2034 Notes is payable annually on June 23, beginning June 23, 2027.
• · The 2030 Notes mature on October 15, 2030; the 2034 Notes mature on June 23, 2034.
• · Prior to the par call date (September 15, 2030 for 2030 Notes; April 23, 2034 for 2034 Notes), the Company may redeem the notes at a make-whole premium plus accrued interest; on or after the par call date, redemption price is 100% of principal plus accrued interest.
• · Upon a change-of-control triggering event, the Company must offer to repurchase the notes at 101% of principal plus accrued interest.
• · Events of default include customary provisions; holders of at least 25% of principal of a series may accelerate that series upon a continuing event of default.
• · The offering was registered under Registration Statement No. 333-277241 (filed February 22, 2024, as amended).

23-06-2026

Aditxt, Inc. entered into Amendment No.1 to its Note Purchase Agreement on June 22, 2026, increasing the aggregate principal amount of senior secured convertible notes from the prior amount to $6,254,355.17 and issued an additional $769,230.77 in principal amount of notes for $500,000 in cash to investor Cavalry Fund I SPV I LP. The notes are secured by substantially all assets of subsidiary Ignite Proteomics LLC and a pledge of the Company's equity in Ignite.

• · The Amendment was executed on June 22, 2026, and filed with the SEC on June 23, 2026.
• · The Additional Notes were issued pursuant to exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
• · The notes are further secured by a pledge of all equity held by Aditxt in Ignite Proteomics LLC.
• · The Amendment also adjusted the definition of 'Closing' and 'Closing Date' to include the additional closing.
• · The previously announced original principal amount in the June 3, 2026 Note Purchase Agreement was $6,638,970.55 (as stated in the amendment), but the filing states the amended aggregate is $6,254,355.17, implying a possible reduction or netting; the exact relationship is not clarified in this filing.

23-06-2026

CBRE GROUP, INC. entered into a $1.0 billion 364-day revolving credit agreement on June 23, 2026, with Wells Fargo Bank as administrative agent and sole lead arranger. The facility provides liquidity for general corporate purposes, including potential acquisitions, and includes a financial covenant (likely a leverage ratio test) and pricing tied to CBRE's senior unsecured debt ratings.

• · The facility's interest rate spreads (Applicable Margin) are determined based on CBRE's senior unsecured long-term debt ratings, ranging from 0.645% to 1.125% over Term SOFR, and facility fees from 0.055% to 0.125%.
• · The agreement includes standard representations and warranties, affirmative and negative covenants (e.g., limits on indebtedness, liens, fundamental changes), and a financial covenant set forth in Section 9.5.
• · Events of default are defined in Article X, enabling acceleration of the facility.
• · The agreement permits the appointment of an Approved Take Out Party for certain obligations, with specific credit quality requirements for the support provider.
• · The facility is unsecured and matures in 364 days from the closing date (June 23, 2026).

23-06-2026

Hayward Holdings, Inc. entered into an Amended and Restated First Lien Credit Agreement dated June 23, 2026, amending and restating the original First Lien Credit Agreement from September 28, 2018. The agreement involves Hayward Industries, Inc. as US Borrower, Hayward Pool Products Canada, Inc. as Canadian Borrower, and Hayward Intermediate, Inc. as Holdings, with Bank of America, N.A. as Administrative Agent and a syndicate of lenders including Goldman Sachs, JPMorgan, MUFG, Truist, U.S. Bank, and Wells Fargo. The agreement establishes revolving credit facilities and term loans, with provisions for incremental credit extensions, financial covenants, and events of default.

• · The agreement amends and restates the original First Lien Credit Agreement dated September 28, 2018, which had been amended multiple times (October 2020, May 2021, December 2022, May 2023).
• · The agreement includes provisions for incremental credit extensions (Section 2.22) and extensions of loans and additional revolving commitments (Section 2.23).
• · The agreement contains financial covenants (Section 6.15) and events of default (Article VII).
• · The agreement includes a provision for cashless rollovers (Section 1.09).

23-06-2026

NNN REIT, Inc. entered into a First Amendment to its Term Loan Agreement on June 23, 2026, securing an additional $200,000,000 in term loans from existing lenders including Wells Fargo, Bank of America, and PNC Bank. The amendment also updates the Applicable Margin pricing grid tied to the company's credit rating, with margins ranging from 0.675% to 1.550% for SOFR loans. The company reaffirmed that no Material Adverse Change has occurred since December 31, 2025, and no Default or Event of Default exists.

• · The additional loans are due and payable in full on the Termination Date and cannot be reborrowed once repaid or prepaid.
• · Proceeds from the additional loans will be used in accordance with Section 7.7 of the Term Loan Agreement.
• · The amendment was executed by the Borrower, Administrative Agent (Wells Fargo), and each Incremental Lender, with conditions precedent including delivery of legal opinions, Notes, and a Notice of Borrowing.
• · The Borrower reaffirmed that its representations and warranties in the Loan Documents remain true and correct in all material respects as of the Effective Date.
• · The agreement is governed by the laws of the State of New York.

23-06-2026

Upwork Inc. entered into a $150 million revolving credit facility with Bank of America as administrative agent, swingline lender, and L/C issuer, along with other lenders. The agreement includes customary covenants, interest rate margins based on leverage ratios, and provisions for letters of credit and swingline loans. No prior-period financial data is provided in this filing, so period-over-period comparisons are not available.

• · The credit agreement includes a $150 million aggregate revolving commitment as of the closing date.
• · Initial Applicable Margin is set at Pricing Level 2 until the first compliance certificate is delivered.
• · Pricing levels are determined by the Consolidated Net Leverage Ratio, with three tiers: <0.75:1.00, 0.75:1.00 to <1.50:1.00, and >1.50:1.00.
• · The agreement includes provisions for incremental facility loans, letters of credit, and swingline loans.
• · The facility is secured by certain subsidiaries as guarantors and includes customary affirmative and negative covenants.
• · No financial performance data (revenue, earnings, etc.) is disclosed in this filing.

23-06-2026

IFF entered into a $1.5B Term Loan Credit Agreement on June 23, 2026, with Wells Fargo as agent and a syndicate of lenders including Bank of America, Barclays, BNP Paribas, Citibank, and JPMorgan. The facility is a delayed draw term loan with an availability period ending September 25, 2026, and proceeds are intended for general corporate purposes. The interest rate is tied to IFF's public debt rating, with margins ranging from 0.875% to 1.500% for Term Benchmark Rate Advances and 0.000% to 0.500% for Base Rate Advances.

• · The facility is a delayed draw term loan with an availability period from June 23, 2026 to September 25, 2026.
• · The agreement includes a financial covenant (Section 5.03) but the specific covenant details are not provided in the excerpt.
• · The interest rate margins are determined by IFF's public debt rating from S&P and Moody's, with five levels ranging from Level 1 (A-/A3 or above) to Level 5 (below BBB-/Baa3).
• · The agreement references '2026 Euro Notes Indebtedness' of €1.800% Senior Notes due 2026, indicating existing euro-denominated debt.

23-06-2026

Invesco Commercial Real Estate Finance Trust, Inc. closed a $1.239 billion collateralized loan obligation (CLO) on June 16, 2026, issuing nine classes of notes through its subsidiary INCREF 2026-FL2 LLC. The transaction raised proceeds to purchase an initial portfolio of collateral interests, repay pre-closing financings, and fund related activities. The CLO includes $743.3 million in AAA-rated Class A notes (60% of total) and $85.2 million in unrated Income Notes, with the company retaining 100% of the riskier Class F, Class G, and Income Notes.

• · The CLO Issuer issued notes under an indenture dated June 16, 2026, with Wilmington Trust as trustee and Computershare as note administrator and custodian.
• · Invesco Advisers, Inc. serves as collateral manager for the Issuer.
• · The Offered Notes were placed via a Placement Agreement dated May 29, 2026, with seven placement agents including Citigroup, Morgan Stanley, Capital One, Wells Fargo, Barclays, Nomura, and BMO.
• · INCREF 2026-FL2 Retention Holder LLC, an indirect wholly-owned subsidiary of the Company, acquired 100% of the Class F Notes, Class G Notes, and Income Notes.
• · The Notes mature in December 2043 unless redeemed earlier.
• · Interest on Class A through E Notes includes a step-up of 0.25% or 0.50% after December 2031 payment date.
• · Failure to pay interest on Class A, A-S, or B Notes constitutes an event of default; deferred interest on lower classes is not an event of default and accrues at the applicable rate.
• · The Secured Notes are limited recourse obligations payable solely from collateral; Income Notes are unsecured.
• · Proceeds were used to purchase an initial portfolio of collateral interests, fund an unused proceeds account, repay pre-closing financings (including repurchase facilities with affiliates of placement agents), and undertake related activities.
• · The initial portfolio was purchased from INCREF CLO Seller LLC under a Collateral Interest Purchase Agreement with repurchase obligations for material breaches or document defects.

23-06-2026

Sensient Technologies Corporation entered into a $400,000,000 credit agreement on June 18, 2026, with CoBank, ACB as administrative agent and CoBank and Compeer Financial, PCA as joint lead arrangers. The facility is a term loan with pricing tied to the company's leverage ratio, ranging from 1.625% to 2.000% over Term SOFR, and includes financial covenants such as a maximum leverage ratio and minimum interest coverage ratio. The agreement also contains standard representations, affirmative and negative covenants, and events of default.

• · The credit agreement is governed by Wisconsin law and includes a $400,000,000 aggregate term loan commitment.
• · Pricing is based on a leverage ratio grid with five levels; the initial pricing is set at Pricing Level III until the first calculation date.
• · Financial covenants include a maximum Leverage Ratio and a minimum Interest Coverage Ratio (specific thresholds not disclosed in the excerpt).
• · The agreement includes provisions for voluntary prepayments, unused commitment fees, and standard events of default.
• · The facility is intended for general corporate purposes, as per Section 2.15 (Use of Advances).

23-06-2026

Clear Secure, Inc. (YOU) through its subsidiary AlClear Holdings, LLC entered into Amendment No. 4 to its credit agreement, reducing total commitments from an undisclosed prior amount to $50.0 million. JPMorgan Chase Bank, N.A. acquired the entire commitments of exiting lenders Goldman Sachs Lending Partners LLC and Wells Fargo Bank, National Association, becoming the sole lender and issuing bank. The amendment simplifies the lending structure and reduces the credit facility size, reflecting a more conservative capital strategy.

• · The amendment became effective on June 23, 2026 (Fourth Amendment Effective Date)
• · JPMorgan acquired all commitments of the two exiting lenders via Assignments and Assumptions effective immediately before the commitment reduction
• · Borrower also granted new short-form trademark security agreement (AlClear, LLC) and patent security agreement (AlClear, LLC and Secure Identity, LLC) as conditions to the amendment
• · Conditions included delivery of legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP, a solvency certificate, and no Material Adverse Effect since December 31, 2024
• · All existing Loan Parties ratified and reaffirmed their security interests and liens in favor of the Administrative Agent and Lenders
• · The amendment fee of $125,000 (0.25% of $50M) is non-refundable and payable on the effective date

23-06-2026

Covenant Logistics Group, Inc. entered into a Twenty-First Amendment to its Credit Agreement with Bank of America and JPMorgan Chase, effective June 17, 2026. The amendment increases the maximum revolver amount to $130,000,000, extends the maturity date to June 17, 2031, adds acquired subsidiaries as borrowers, and provides additional flexibility to incur unsecured debt. No financial performance metrics or period-over-period comparisons are provided in this filing.

• · The original Credit Agreement was dated September 23, 2008.
• · The amendment adds certain acquired subsidiaries as borrowers.
• · The company now has additional flexibility to incur unsecured debt.
• · The full text of the Twenty-First Amendment will be filed with the Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.

23-06-2026

AMASS Brands Inc. invested $1.535M in AFTERDREAM, Inc. via a SAFE agreement with a $7.5M post-money valuation cap, initially set at $1.435M and subsequently increased by $100,000. The investment provides AMASS with rights to future equity upon an equity financing, liquidity event, or dissolution event, but no immediate financial returns or operational synergies are disclosed.

• · The SAFE automatically converts into shares upon an Equity Financing, Liquidity Event, or Dissolution Event, with conversion terms based on the greater of two formulas.
• · The SAFE is non-transferable without prior written consent, subject to customary exceptions.
• · The Amendment was executed on June 17, 2026, one day after the original SAFE.
• · The Post-Money Valuation Cap of $7.5M remained unchanged after the amendment.
• · The filing includes redacted exhibits under Item 601(b)(10)(iv) of Regulation S-K.

23-06-2026

FiEE, Inc. entered into a Sales Agreement with A.G.P./Alliance Global Partners on June 23, 2026, to conduct an at-the-market offering of up to $6,272,809 in common stock. The Company has no obligation to sell any Shares and may suspend or terminate the agreement at any time. The Sales Agent will receive a 3.25% commission on gross proceeds, and the Company will reimburse certain expenses.

• · The Sales Agreement allows for at-the-market sales on Nasdaq under Rule 415(a)(4).
• · The Shares will be sold pursuant to a shelf registration statement (File No. 333-295474) declared effective June 11, 2026.
• · The Company may also sell Shares to the Sales Agent as principal under separate terms agreements.
• · The Sales Agent is entitled to customary indemnification and contribution rights, including for Securities Act liabilities.
• · The legal opinion of K&L Gates LLP was filed as Exhibit 5.1.
• · The Company is incorporated in Delaware and its principal executive offices are in Osaka, Japan.
• · The closing date of the filing is June 23, 2026.

23-06-2026

CIM Opportunity Zone Fund, L.P. disclosed entry into a material financing agreement dated June 16, 2026, among Westlands Grape, LLC and affiliates as borrowers, with Wells Fargo Bank, N.A. as administrative agent and Truist Bank as collateral agent. The agreement establishes construction loan, bridge loan, term loan, and letter of credit facilities to fund the Westlands Grape project, with specific conditions, covenants, and events of default. No specific monetary amounts or period-over-period comparisons are provided in this filing.

• · The financing agreement includes construction loan, bridge loan, term loan, and letter of credit facilities.
• · Key parties include Wells Fargo Bank, N.A. as Administrative Agent and Truist Bank as Collateral Agent.
• · The agreement contains conditions precedent, representations and warranties, affirmative and negative covenants, events of default, and remedies.
• · Certain information has been redacted as not material and confidential.
• · The filing is an 8-K dated June 23, 2026, referencing the agreement dated June 16, 2026.

23-06-2026

Office Properties Income Trust (OPIRQ) has emerged from Chapter 11 bankruptcy reorganization, issuing shares, warrants, and new debt in exchange for existing liabilities, resulting in material cancellation of debt (COD) income and an ownership change under IRC Section 382. The company expects to continue its historic real estate leasing business for at least two years, but the reorganization creates significant tax uncertainties, including potential limitations on net operating losses (NOLs) and increased taxable income that could strain its ability to maintain REIT qualification. The company believes it may qualify for an exception to Section 382 limitations, but this is uncertain and subject to IRS challenge.

• · The aggregate value of common shares, warrants, and new debt issued was materially less than the balance of liabilities extinguished.
• · COD income will first reduce accumulated NOLs dollar for dollar, with any remainder reducing asset basis; the company may elect to offset COD income first against depreciable asset basis.
• · The ownership change under IRC Section 382 results in a Net Unrealized Built-In Loss (NUBIL) because the aggregate tax basis of assets far exceeded their aggregate value at the time of the change.
• · If the company does not qualify for the Section 382 exception, annual use of beneficial tax attributes would be limited to the product of aggregate share value post-reorganization multiplied by an applicable IRS-determined interest rate.
• · If a subsequent ownership change occurs within two years of emergence, accumulated beneficial tax attributes and NUBIL-related losses/deductions would be effectively eliminated.
• · The company will likely not make final determinations on COD income amounts, attribute reductions, or Section 382 exception qualification until filing its 2026 federal income tax return.
• · The company has elected REIT status since 2009 and believes it has continued to qualify, but the reorganization increases taxable income, putting material strain on distribution requirements to maintain REIT status.
• · Noncorporate U.S. shareholders may be eligible for lower effective tax rates on dividends under Section 199A, but no dividends are eligible for the dividends received deduction.
• · Distributions in excess of earnings and profits are treated as returns of capital, reducing basis, and any excess over basis is treated as capital gain.

23-06-2026

Boundless Bio (Nasdaq: BOLD) and private company Serapha Bio entered a definitive all-stock merger agreement announced June 23, 2026; post-closing the combined company will operate as Serapha Bio, Inc. and is expected to trade on Nasdaq under ticker “AATD”. Serapha secured commitments for a concurrent private placement of approximately $230 Million (of which approximately $138 Million has been funded and approximately $92 Million is expected to close substantially concurrently with the merger), and Boundless expects to declare a pre-closing cash dividend to pre-merger Boundless stockholders currently expected to be approximately $44 to $48 Million. The deal implies pre-merger Boundless stockholders will own approximately 3.7% of the combined company and pre-merger Serapha stockholders (including investors in the pre-closing financings) will own approximately 96.3% at closing. However, closing is subject to customary conditions (stockholder approvals, Nasdaq listing approval, Form S-4 effectiveness, Hart-Scott-Rodino waiting period clearance), and the announced cash runway projection and clinical benefits of SERP-01 are forward-looking and subject to clinical and regulatory risk.

• · The combined company’s cash and cash equivalents balance at closing, including funds from the private placement, is expected to fund Serapha’s operations into the second half of 2029 and provide runway through Phase 2 completion and Phase 3 initiation for SERP-01 (forward-looking projection, subject to change).
• · Serapha licensed SERP-01 from YolTech Therapeutics in June 2026 in exchange for an upfront cash payment and a minority equity stake in Serapha; YolTech retains Greater China development/commercial rights and has been enrolling patients in an Investigator-Initiated Trial at Renji Hospital, Shanghai.
• · YolTech is eligible for tiered royalties on net sales of SERP-01 in addition to the milestone pool of over $2 Billion.
• · The transaction was unanimously approved by the Boards of Directors of both companies and is expected to close in the fourth quarter of 2026, subject to stockholder approvals and regulatory/filing conditions.
• · Prior to closing, Boundless expects to declare a cash dividend to distribute excess net cash, with the amount subject to adjustment based on Boundless Bio’s net cash at closing and merger agreement terms.

23-06-2026

Backblaze announced a five-year, multi-exabyte data storage agreement with CoreWeave valued at $335 million. Under the deal, Backblaze will provide HDD-based storage capacity for CoreWeave's AI Object Storage, supporting AI workloads such as training, inference, and checkpointing. The agreement positions Backblaze as a key storage provider for AI infrastructure, though no specific revenue or margin impact was disclosed.

• · The agreement is for five years and multi-exabyte scale.
• · Backblaze's HDD-based storage tiers will be used in CoreWeave AI Object Storage.
• · Customers using CoreWeave AI Object Storage with LOTA distributed cache will have immediate access to new service tiers without code modifications.
• · CoreWeave serves 9 of the top 10 AI model providers.
• · Backblaze serves over 100,000 customers (press release) or over 500,000 customers (about section).
• · The press release includes forward-looking statements and risk factors related to go-to-market transformation, AI growth, competition, pricing changes, and supply chain disruption.

23-06-2026

Sangamo Therapeutics filed for Chapter 11 bankruptcy on June 23, 2026, and entered into stalking horse asset purchase agreements with Eli Lilly and Astellas to sell substantially all assets. Lilly will acquire technology platforms including STAC-BBB capsid and zinc finger protein technology for $50 million, while Astellas will acquire the Fabry disease candidate isaralgagene civaparvovec for $25 million upfront plus up to $25 million in milestones. The company also secured a $30 million debtor-in-possession financing facility from Northridge ATM, LLC, subject to court approval, with an initial interim draw of up to $10.5 million.

• · The company's common stock was suspended from Nasdaq and began trading on OTCQB on May 5, 2026, due to failure to meet minimum bid price requirement.
• · The Chapter 11 case (Case No. 26-10989) was filed in the U.S. Bankruptcy Court for the District of Delaware.
• · Court documents are available at https://www.veritaglobal.net/SangamoTherapeutics.
• · The Lilly Stalking Horse APA includes the right to receive future milestone and royalty payments from certain outlicensing agreements.
• · The Astellas Stalking Horse APA includes up to $25 million in additional milestone payments.
• · The DIP Facility is secured by a first priority lien on substantially all assets and a superpriority claim, subject to customary carve-outs.
• · The DIP Facility requires compliance with a 13-week budget.

23-06-2026

HeartSciences Inc. (HSCSW) announced a definitive merger agreement with Fortitude Mining Holdings, a vertically-integrated Zcash mining platform wholly-owned by Digital Currency Group (DCG). The all-stock transaction is expected to close in H2 2026, with the combined company operating under the Fortitude brand and trading on Nasdaq under the ticker symbol "TUDE". DCG is expected to own approximately 95% of the combined company on a fully diluted basis, while HeartSciences shareholders will retain a minority stake. The deal allows HeartSciences to continue advancing its MyoVista Insights AI-ECG technology with greater focus, but existing HeartSciences shareholders face significant dilution.

• · Fortitude began mining ZEC in 2019 and has scaled annualized production to 157,000 ZEC (approx. 366 ZEC per day) as of May 31, 2026.
• · Zcash has delivered a trailing twelve-month return of approximately 1,000%+ as of June 15, 2026.
• · Fortitude is currently wholly-owned by Digital Currency Group (DCG).
• · Current HeartSciences CEO Andrew Simpson is expected to continue to lead the healthcare business unit after closing.
• · Fortitude will host an investor conference call on June 23, 2026 at 9:00 A.M. EST.
• · Advisors: Canaccord Genuity LLC and Ducera Partners for Fortitude; Houlihan Capital for HeartSciences.

23-06-2026

Kimbell Royalty Partners, LP closed a $145.9 million acquisition of mineral and royalty interests from Mesa Royalties (portfolio companies of NGP-managed funds) in the Permian Basin. The consideration consisted of $44.0 million in cash and approximately 6.9 million newly issued common units valued at $101.9 million. The acquired assets are expected to produce approximately 1,390 Boe/d over the next twelve months, with a diversified footprint across 16 Permian counties, concentrated in the Delaware Basin (70%) and Midland Basin (30%).

• · Kimbell is entitled to all cash flow from production attributable to the Acquired Assets since the effective date of June 1, 2026.
• · Revenues and certain other operating statistics under GAAP will be recorded for the Acquisition beginning on the closing date of June 22, 2026.
• · The purchase price reflects Kimbell’s $14.70 per unit closing price as of June 22, 2026.
• · Kimbell owns mineral and royalty interests in over 17 million gross acres in 28 states and in every major onshore basin in the continental United States, including ownership in more than 135,000 gross wells.

23-06-2026

Nordicus Partners Corporation issued 201,500 restricted shares of common stock at $2.75 per share to five private investors in March and April 2026, with the private offering closed on June 23, 2026. The shares were issued under exemptions from registration, and no underwriting discounts or commissions were paid. No financial performance data or period-over-period comparisons are available in this filing.

• · The shares were issued at $0.01 par value per share.
• · The offering was exempt under Section 4(a)(2) of the Securities Act and/or Rule 506(b) and (c) of Regulation D, as well as Regulation S for non-U.S. persons.
• · No underwriters or agents were involved, and no underwriting discounts or commissions were paid.
• · The securities are subject to transfer restrictions and bear a restrictive legend.